Michael P Dube Intellia Therapeutics, Inc. (NTLA) insider trading activity

Michael P Dube is VP, Chief Accounting Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 52,277 shares of NTLA, which is worth approximately $454,809. The most recent transaction as insider was on Jan 05, 2026, when has been sold 2,989 shares (Common Stock) at a price of $9.21 per share, resulting in proceeds of $27,528. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.3K

5.41% 3M change

14.54% 12M change

Total Value Held $454,809

Michael P Dube Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2026	SELL Open market or private sale	$27,528 $9.21 p/Share	2,989 Reduced 5.41%	52,277 Common Stock
Oct 01 2025	SELL Open market or private sale	$32,517 $17.38 p/Share	1,871 Reduced 3.27%	55,266 Common Stock
Jul 02 2025	SELL Open market or private sale	$24,904 $9.95 p/Share	2,503 Reduced 4.2%	57,137 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	14,000 Added 19.01%	59,640 Common Stock
Jan 03 2025	SELL Open market or private sale	$16,710 $12.18 p/Share	1,372 Reduced 2.92%	45,640 Common Stock
Oct 02 2024	SELL Open market or private sale	$38,248 $19.01 p/Share	2,012 Reduced 4.1%	47,012 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	17,801 Added 26.64%	49,024 Common Stock

MPD

Michael P Dube

VP, Chief Accounting Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Value

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Intellia Therapeutics, Inc.

Track Activities on NTLA

Account